Los Angeles Capital Management
CRMD icon

Los Angeles Capital Management’s CorMedix CRMD Stock Holding History

Los Angeles Capital Management’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.94K Sell
581
-60,974
-99% -$451K ﹤0.01% 2187
2025
Q4 		$715K Buy
61,555
+23,760
+63% +$263K ﹤0.01% 760
2025
Q3 		$440K Buy
+37,795
New +$457K ﹤0.01% 979

Other funds holding CRMD

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Los Angeles Capital Management's CRMD Position: Q1 2026 in Review

Los Angeles Capital Management reduced its CorMedix (CRMD) stake by 99% in Q1 2026, selling an estimated $451K and leaving 581 shares worth $3.94K. The position accounts for ﹤0.01% of the portfolio, ranked #2187.

Los Angeles Capital Management first reported a position in CRMD in Q3 2025 and has held it in 3 quarters since. The position peaked at $715K in Q4 2025. 187 funds tracked by Wall St. Rank hold CRMD as of Q1 2026.

  • Los Angeles Capital Management held 581 shares of CorMedix worth $3.94K as of Q1 2026.
  • Los Angeles Capital Management sold 60,974 CorMedix shares in Q1 2026, an estimated $451K.
  • CorMedix made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q1 2026, its #2187 holding.
  • Los Angeles Capital Management first reported a position in CorMedix in Q3 2025 and has held it in 3 quarters since.
  • Los Angeles Capital Management's CorMedix position peaked at $715K in Q4 2025.
  • 187 funds tracked by Wall St. Rank held CorMedix as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.